Reqbio Achieves ISO 9001:2015 Quality Management System Certification

Home> Company> Conferences&Events> Reqbio Achieves ISO 9001:2015 Quality Management System Certification

Reqbio Achieves ISO 9001:2015 Quality Management System Certification

Certification covers drug research target model development and in vitro compound activity evaluation, valid through September 23, 2029

September 24, 2026 · Shanghai

Shanghai, September 24, 2026 — Reqbio (Shanghai) Bioscience Co., Ltd. (“Reqbio”) has been awarded the GB/T 19001-2016 / ISO 9001:2015 Quality Management System certificate by Beijing Xinjiyuan Certification Co., Ltd. (Certificate No. 19826Q02638R001). The certification covers the “R&D of drug research target models (not involving pathogenic microorganisms), and in vitro activity evaluation services for compounds.” The certificate is valid from September 24, 2026 through September 23, 2029.

ISO 9001 is the internationally recognized standard for quality management systems and one of the most widely adopted management standards worldwide. The audit was conducted by a certification body accredited by the China National Accreditation Service for Conformity Assessment (CNAS). The certificate carries both the IAF Multilateral Recognition Arrangement (MLA) mark and the CNAS accreditation mark (CNAS C178-M), indicating that the company's quality management system conforms to internationally accepted requirements and that the certification is recognized under the IAF multilateral mutual recognition framework.

The certification scope spans the company's core workflows end to end: from requirements review, study design, model construction and validation for target models, through sample management, assay execution, data recording and report delivery for in vitro activity evaluation of compounds. To meet the standard's requirements, Reqbio established and now operates a systematic set of management practices covering document and record control, personnel competence and training, instrument, equipment and reagent management, in-process quality control, data integrity and traceability, customer communication and continual improvement — validated through internal audits and a management review.

“ISO 9001 is not a one-off credential. It is the process of writing ‘delivering reliable data consistently’ into our SOPs and into every experimental record. Target models and in vitro activity evaluation sit at the very front of the drug discovery chain. When clients entrust a project to us, what they are really trusting is our data. ISO 9001 gives that trust a foundation that can be audited, traced, and continuously improved.”
— Quality Management Lead, Reqbio

The company added that it will continue to deepen the integration of the quality management system with day-to-day operations — investing further in standardized model construction, electronic traceability of experimental data, and a competence matrix for laboratory staff — and will undergo scheduled surveillance audits as required by the certification.

About Reqbio

Reqbio (Shanghai) Bioscience Co., Ltd. focuses on the R&D of drug research target models (not involving pathogenic microorganisms) and in vitro activity evaluation services for compounds, providing technical support spanning target model construction through in vitro activity screening for innovative drug discovery organizations. Grounded in standardized experimental workflows, traceable data management and consistent delivery, the company aims to be a trusted technical partner at the drug discovery stage.